+ All Categories
Home > Documents > Cancer: Are we closer to a cure? Thanks to: Jesse Boehm, Ph.D. Broad Institute of Harvard and MIT...

Cancer: Are we closer to a cure? Thanks to: Jesse Boehm, Ph.D. Broad Institute of Harvard and MIT...

Date post: 23-Dec-2015
Category:
Upload: frank-hunter
View: 215 times
Download: 0 times
Share this document with a friend
Popular Tags:
60
Cancer: Are we closer to a cure? Thanks to: Jesse Boehm, Ph.D. Broad Institute of Harvard and MIT Cambridge, MA
Transcript
Page 1: Cancer: Are we closer to a cure? Thanks to: Jesse Boehm, Ph.D. Broad Institute of Harvard and MIT Cambridge, MA.

Cancer:Are we closer to a cure?

Thanks to: Jesse Boehm, Ph.D.

Broad Institute of Harvard and MITCambridge, MA

Page 2: Cancer: Are we closer to a cure? Thanks to: Jesse Boehm, Ph.D. Broad Institute of Harvard and MIT Cambridge, MA.

Cancer is a huge public health problem

Page 3: Cancer: Are we closer to a cure? Thanks to: Jesse Boehm, Ph.D. Broad Institute of Harvard and MIT Cambridge, MA.

Overall mortality rates have not changed for cancer…

De

ath

s p

er

100

,00

0 p

eop

le

Year

CDC Mortality Data

Page 4: Cancer: Are we closer to a cure? Thanks to: Jesse Boehm, Ph.D. Broad Institute of Harvard and MIT Cambridge, MA.

2015: A unprecedented moment in the history of cancer

Before BRAF drug 6 weeks later

Example: BRAF-mutant melanoma

2015: A unprecedented moment in the history of cancer

Page 5: Cancer: Are we closer to a cure? Thanks to: Jesse Boehm, Ph.D. Broad Institute of Harvard and MIT Cambridge, MA.

How did this happen?

•Identification in 2002 that the BRAF protein is mutated in melanoma

•Develop a powerful drug that blocks the BRAF protein

•Launch a focused clinical trial by enrolling only patients with molecular biomarker that predicts response (sequence tumor)

•Understand relationship between having the mutation and responding to therapy•Clinical trials are thus smaller, faster and cheaper

•See amazing clinical success (~2009) and FDA approval (2011)

Page 6: Cancer: Are we closer to a cure? Thanks to: Jesse Boehm, Ph.D. Broad Institute of Harvard and MIT Cambridge, MA.

Before Iressa treatment After 3 months of Iressa treatment

We have made HUGE advances in other cancers!!!!

Image providedby B. Johnson

Page 7: Cancer: Are we closer to a cure? Thanks to: Jesse Boehm, Ph.D. Broad Institute of Harvard and MIT Cambridge, MA.

2003 2011 2015 2023

Empiric/Experimental

(organ)

Precise/Targeted

(gene)

Personalized(patient)

Progress/The Future: Two decades of cancer medicine

Page 8: Cancer: Are we closer to a cure? Thanks to: Jesse Boehm, Ph.D. Broad Institute of Harvard and MIT Cambridge, MA.

Discovering Cancer Geneswhere we are now

• Mapping cancer genes highlights potential drug targets

• Human genome mapped in 2001• First cancer genome decoded in 2009

• 2014: Broad has mapped over 15,000 cancer genomes across >25 tumor types, produced the world’s standard computational tools

• We will soon have the complete map of common mutations in every major cancer type

• Major discoveries in nearly every cancer type; genome-guided medicine becoming reality for patients

Page 9: Cancer: Are we closer to a cure? Thanks to: Jesse Boehm, Ph.D. Broad Institute of Harvard and MIT Cambridge, MA.

Many cancer patients today are having their tumor genomes sequenced to predict treatments

patient tumor clinical sequencing and pathology

mutations(10-150)

cancer drugs that each target one of

the mutations

We don’t have all of the drugs yet, but now that we know what proteins to block, drug companies are developing

successful cancer drugs at a much faster pace!

Page 10: Cancer: Are we closer to a cure? Thanks to: Jesse Boehm, Ph.D. Broad Institute of Harvard and MIT Cambridge, MA.

We have also made HUGE advances in prevention!!!!

Page 11: Cancer: Are we closer to a cure? Thanks to: Jesse Boehm, Ph.D. Broad Institute of Harvard and MIT Cambridge, MA.

The Fundamentals of Cancer

What is cancer?

Molecular causes of cancer

How faulty genes are involved

How a cancer cell becomes dangerous

Page 12: Cancer: Are we closer to a cure? Thanks to: Jesse Boehm, Ph.D. Broad Institute of Harvard and MIT Cambridge, MA.

What is Cancer?

•An uncontrolled growth of cells

•A genetic disease

•A family of similar diseases

newscenter.cancer.gov

Page 13: Cancer: Are we closer to a cure? Thanks to: Jesse Boehm, Ph.D. Broad Institute of Harvard and MIT Cambridge, MA.

An Uncontrolled Growth of Cells

•Healthy cells turn into the enemy•divide too quickly or abnormally•become abnormal shapes and sizes•grow in all directions

•Cells stop listening to the body, which is telling them to stop!

.. ... .. ... .. ..... .. ... .. ..... .. .......

structuralsupport

dividing cells

non-dividing cells

normalskin

skin cancer

Page 14: Cancer: Are we closer to a cure? Thanks to: Jesse Boehm, Ph.D. Broad Institute of Harvard and MIT Cambridge, MA.

A Genetic Disease

Normal Cells

Cancer Cells

•Mutations in DNA can make normal cells become cancerous

•These can be inherited or spontaneous

.. ... .. ... .. ..... .. .

Page 15: Cancer: Are we closer to a cure? Thanks to: Jesse Boehm, Ph.D. Broad Institute of Harvard and MIT Cambridge, MA.

A Family of Similar Diseases

•Carcinomas: from cells which protect the body from air and internal fluids

•Sarcomas: from cells in supportive tissue

•Leukemias and Lymphomas: from cells in the blood andimmune system

newscenter.cancer.gov

Page 16: Cancer: Are we closer to a cure? Thanks to: Jesse Boehm, Ph.D. Broad Institute of Harvard and MIT Cambridge, MA.

The Fundamentals of Cancer

What is cancer?

Molecular causes of cancer

How faulty genes are involved

How a cancer cell becomes dangerous

Page 17: Cancer: Are we closer to a cure? Thanks to: Jesse Boehm, Ph.D. Broad Institute of Harvard and MIT Cambridge, MA.

Common causes of cancer

•Chemicals (e.g. tobacco, asbestos)•Viruses (e.g. HPV) •Radiation from the sun

What do all of these have in common?

They all lead to MUTATIONS in the DNA of your cells

They are called MUTAGENS

Can also be predisposed to getting cancer by inheriting mutations from parents

newscenter.cancer.gov

Page 18: Cancer: Are we closer to a cure? Thanks to: Jesse Boehm, Ph.D. Broad Institute of Harvard and MIT Cambridge, MA.

Facts: Smoking and Alcohol• Cigarette smoking causes 87 percent of lung cancer deaths

and is responsible for most cancers of the larynx, oral cavity and pharynx, esophagus, and bladder

• Tobacco smoke contains thousands of chemical agents, including over 60 substances that are known to cause cancer.

• Alcohol use has been implicated in the development of a number of cancers • Risk increases >1 drink for women or 2 drinks for men/day

Page 19: Cancer: Are we closer to a cure? Thanks to: Jesse Boehm, Ph.D. Broad Institute of Harvard and MIT Cambridge, MA.

Causes of Cancer

Cancer Cells

What are mutations and how do they cause normal cells to become

cancer cells?

Page 20: Cancer: Are we closer to a cure? Thanks to: Jesse Boehm, Ph.D. Broad Institute of Harvard and MIT Cambridge, MA.

How Could a Mutant Protein Make Cells Divide Out of Control?

mutant protein cancer cells

?

mutant DNA

Page 21: Cancer: Are we closer to a cure? Thanks to: Jesse Boehm, Ph.D. Broad Institute of Harvard and MIT Cambridge, MA.

What Happens Normally?

DNA Bases

Normal DNA

A T

C G

CG

A T

CG

A T

C G

A

A

T

T

Page 22: Cancer: Are we closer to a cure? Thanks to: Jesse Boehm, Ph.D. Broad Institute of Harvard and MIT Cambridge, MA.

Normal DNA

What Happens Normally?

A T

C G

CG

A T

CG

A T

C G

A

C

G

A

G

A

C

mRNA

DNA is transcribed (copied) to RNA

A

A

T

T

A

A

Page 23: Cancer: Are we closer to a cure? Thanks to: Jesse Boehm, Ph.D. Broad Institute of Harvard and MIT Cambridge, MA.

What Happens Normally?

Normal Protein

mRNA

Translation: Proteins are made from mRNA

aminoacids

Normal DNA

A T

C G

CG

A T

CG

A T

C G

A

C

G

A

G

A

C

A

A

T

T

A

A

Page 24: Cancer: Are we closer to a cure? Thanks to: Jesse Boehm, Ph.D. Broad Institute of Harvard and MIT Cambridge, MA.

A T

C G

CG

A T

CG

Changed DNA

A T

C G

DELETION

A Mutation Occurs

A T

Page 25: Cancer: Are we closer to a cure? Thanks to: Jesse Boehm, Ph.D. Broad Institute of Harvard and MIT Cambridge, MA.

Changed DNA

A Mutant Protein is Made

A T

C G

CG

A T

CG

A T

C G

A

C

G

A

G

A

C

Changed mRNA

DELETION

Normal Protein

Abnormal/ Mutant Protein

A T

A

A

AA T

Page 26: Cancer: Are we closer to a cure? Thanks to: Jesse Boehm, Ph.D. Broad Institute of Harvard and MIT Cambridge, MA.

A Mutant Protein is Made

Normal Protein

Changed DNA

A

T

C G

CG

A T

CG

C G

A

T

Abnormal/ Mutant Protein

A T

A T

Page 27: Cancer: Are we closer to a cure? Thanks to: Jesse Boehm, Ph.D. Broad Institute of Harvard and MIT Cambridge, MA.

How Could a Mutant Protein Make Cells Divide Out of Control?

mutant protein cancer cells

?

Page 28: Cancer: Are we closer to a cure? Thanks to: Jesse Boehm, Ph.D. Broad Institute of Harvard and MIT Cambridge, MA.

The Cell Cycle Controls Cell Division

Cell Cycle

Cells divide (mitosis)

DNA Synthesis

Growth

Growth

Page 29: Cancer: Are we closer to a cure? Thanks to: Jesse Boehm, Ph.D. Broad Institute of Harvard and MIT Cambridge, MA.

The Cell Makes Sure That There are no Problems

Cell Cycle

Did division go correctly?

Is my DNA copied

correctly?

Am I big enough?

Am I ready to divide?

Page 30: Cancer: Are we closer to a cure? Thanks to: Jesse Boehm, Ph.D. Broad Institute of Harvard and MIT Cambridge, MA.

The Cell Cycle Has Checkpoints

Cell Cycle

Did division go correctly?

Is my DNA copied

correctly?

Am I big enough?

Am I ready to divide?

Page 31: Cancer: Are we closer to a cure? Thanks to: Jesse Boehm, Ph.D. Broad Institute of Harvard and MIT Cambridge, MA.

The Normal Protein Functions at a Cell Cycle Checkpoint

Cell Cycle

Normal Protein

Is my DNA copied correctly?

Page 32: Cancer: Are we closer to a cure? Thanks to: Jesse Boehm, Ph.D. Broad Institute of Harvard and MIT Cambridge, MA.

The Mutant Protein Allows The Cell to Divide Out of Control

Cell Cycle

I can’t stop and check if the DNA has been copied

correctly!!!

Normal Protein

Abnormal/ Mutant Protein

go!

Page 33: Cancer: Are we closer to a cure? Thanks to: Jesse Boehm, Ph.D. Broad Institute of Harvard and MIT Cambridge, MA.

The Fundamentals of Cancer

What is cancer?

Molecular causes of cancer

How faulty genes are involved

How a cancer cell becomes dangerous

Page 34: Cancer: Are we closer to a cure? Thanks to: Jesse Boehm, Ph.D. Broad Institute of Harvard and MIT Cambridge, MA.

How Faulty Genes are Involved

Not every gene leads to cancer when mutated

Mutations in two specific categories of genes can lead to cancer

• Tumor-Suppressor Genes

• Oncogenes

Page 35: Cancer: Are we closer to a cure? Thanks to: Jesse Boehm, Ph.D. Broad Institute of Harvard and MIT Cambridge, MA.

How Faulty Genes are Involved

Not every gene leads to cancer when mutated

Mutations in two specific categories of genes can lead to cancer

• Tumor-Suppressor Genes

• Oncogenes

Page 36: Cancer: Are we closer to a cure? Thanks to: Jesse Boehm, Ph.D. Broad Institute of Harvard and MIT Cambridge, MA.

Inactivated Tumor Suppressor Genes Lead to Cancer

•Tumor Suppressor (TS) genes normally inhibit cell growth

•Mutations in TS genes may inactivate them, so that they cannot stop cell-growth

•TS genes include p53 and BRCA1/2

cell TS gene

Page 37: Cancer: Are we closer to a cure? Thanks to: Jesse Boehm, Ph.D. Broad Institute of Harvard and MIT Cambridge, MA.

How Faulty Genes are Involved

Not every gene leads to cancer when mutated

Mutations in two specific categories of genes can lead to cancer

• Tumor-Suppressor Genes

• Oncogenes

Page 38: Cancer: Are we closer to a cure? Thanks to: Jesse Boehm, Ph.D. Broad Institute of Harvard and MIT Cambridge, MA.

Activated Oncogenes Lead to Cancer

•Oncogenes normally promote cell growth carefully

•Mutations in oncogenes may over-activate them, so that they always promote cell-growth

•One well-known oncogene is called RAS

cell oncogene

Page 39: Cancer: Are we closer to a cure? Thanks to: Jesse Boehm, Ph.D. Broad Institute of Harvard and MIT Cambridge, MA.

Mutations in Specific Genes Turn a Normal Cell into a Cancer Cell

Mutate tumor suppressor genes, turning these genes OFF

Mutate oncogenes, turning these genes ON

normal cell cancer cell

mutations

1 2 3 4 5 6…..

Page 40: Cancer: Are we closer to a cure? Thanks to: Jesse Boehm, Ph.D. Broad Institute of Harvard and MIT Cambridge, MA.

The Fundamentals of Cancer

What is cancer?

Molecular causes of cancer

How faulty genes are involved

How a cancer cell becomes dangerous

Page 41: Cancer: Are we closer to a cure? Thanks to: Jesse Boehm, Ph.D. Broad Institute of Harvard and MIT Cambridge, MA.

Benign vs. Malignant

Benign: A non-malignant tumor lacking the ability to invade surrounding normal tissue

Malignant: A tumor that tends to grow, has the capacity to invade nearby tissue and spreads through the blood stream

adapted from “Concise Dictionary of Biomedicine and Molecular Biology,” Pei-Show Juo, 1996

Page 42: Cancer: Are we closer to a cure? Thanks to: Jesse Boehm, Ph.D. Broad Institute of Harvard and MIT Cambridge, MA.

How cancer cells become dangerous

•A cancer cell on its own will not cause you harm

•To become the disease “Cancer” the cell must:

•1) Form a tumor (at least)

•2) Recruit a blood supply = angiogenesis(solid tumors only)

•3) Spread to other parts of the body = metastasis (advanced stages)

Page 43: Cancer: Are we closer to a cure? Thanks to: Jesse Boehm, Ph.D. Broad Institute of Harvard and MIT Cambridge, MA.

Metastasis

Cells then invade new tissues, and

begin to grow

Cells travel through the blood stream to

distant sites

Cancer cells enter blood vessels

Page 44: Cancer: Are we closer to a cure? Thanks to: Jesse Boehm, Ph.D. Broad Institute of Harvard and MIT Cambridge, MA.

Cancer treatment

Tumor

Lung

Heart

Page 45: Cancer: Are we closer to a cure? Thanks to: Jesse Boehm, Ph.D. Broad Institute of Harvard and MIT Cambridge, MA.

Surgery

Radiation

Drugs (chemotherapy)

There are different types of treatments

Page 46: Cancer: Are we closer to a cure? Thanks to: Jesse Boehm, Ph.D. Broad Institute of Harvard and MIT Cambridge, MA.

Cancer can be local or metastatic

local (one primary tumor)

metastatic (secondary tumors)

Page 47: Cancer: Are we closer to a cure? Thanks to: Jesse Boehm, Ph.D. Broad Institute of Harvard and MIT Cambridge, MA.

Cancer therapy: local and systemic

LOCAL: surgery and radiation

SYSTEMIC: chemotherapy,

etc.

Rx

Page 48: Cancer: Are we closer to a cure? Thanks to: Jesse Boehm, Ph.D. Broad Institute of Harvard and MIT Cambridge, MA.

The problem of Selectivity of chemotherapy and radiation

Why need targeted therapy?

cancer cells

normal cells

Page 49: Cancer: Are we closer to a cure? Thanks to: Jesse Boehm, Ph.D. Broad Institute of Harvard and MIT Cambridge, MA.

The problem of Selectivity of chemotherapy and radiation

Why need targeted therapy?

cancer cells

normal cells

Page 50: Cancer: Are we closer to a cure? Thanks to: Jesse Boehm, Ph.D. Broad Institute of Harvard and MIT Cambridge, MA.

The problem of Selectivity of chemotherapy and radiation

Why need targeted therapy?

cancer cells

normal cells

Page 51: Cancer: Are we closer to a cure? Thanks to: Jesse Boehm, Ph.D. Broad Institute of Harvard and MIT Cambridge, MA.

Killing a fly with a cannon ball?

Page 52: Cancer: Are we closer to a cure? Thanks to: Jesse Boehm, Ph.D. Broad Institute of Harvard and MIT Cambridge, MA.

We can kill the fly but…

Page 53: Cancer: Are we closer to a cure? Thanks to: Jesse Boehm, Ph.D. Broad Institute of Harvard and MIT Cambridge, MA.

Problem with selectivity leads to side effects

SIDE EFFECTS!

• hair follicles: hair loss • bone marrow: immune defense,

anemia, clotting problems• gut lining: diarrhea• skin: flaky/scaly skin

cancer cellsnormal cells

Page 54: Cancer: Are we closer to a cure? Thanks to: Jesse Boehm, Ph.D. Broad Institute of Harvard and MIT Cambridge, MA.

How can we improve cancer therapy?

Pick a better TARGET!

Normal cell Cancer cell

Page 55: Cancer: Are we closer to a cure? Thanks to: Jesse Boehm, Ph.D. Broad Institute of Harvard and MIT Cambridge, MA.

Goal: Discover new drugs that attack most important mutations

Example: MCL1 gene helps cells survive

Progress: Discovery of new early stage drugs that block MCL1 in cancer cells

normal breast cancer

MCL1 gene

ALIVE DEAD

Turn off MCL1 in lab

Page 56: Cancer: Are we closer to a cure? Thanks to: Jesse Boehm, Ph.D. Broad Institute of Harvard and MIT Cambridge, MA.

Goal: Discover new drugs that attack most important mutations

Example: MCL1 gene helps cells survive

Want to explore this further? Check this out:

Progress: Discovery of new early stage drugs that block MCL1 in cancer cells

500,000 chemicals robotics

http://www.hhmi.org/biointeractive/bcr-abl-cancer-protein-structure-function

Page 57: Cancer: Are we closer to a cure? Thanks to: Jesse Boehm, Ph.D. Broad Institute of Harvard and MIT Cambridge, MA.

2015 Revolution in Cancer Therapy #1: Using the immune system to fight cancer

• Amazing, unpredecented successes (2013-2015), never before seen!

• A revolution in cancer therapy

Page 58: Cancer: Are we closer to a cure? Thanks to: Jesse Boehm, Ph.D. Broad Institute of Harvard and MIT Cambridge, MA.

2015 Revolution in Cancer Therapy #2: Resurrect “failed” drugs by finding genes that allowed rare patients to respond!

Page 59: Cancer: Are we closer to a cure? Thanks to: Jesse Boehm, Ph.D. Broad Institute of Harvard and MIT Cambridge, MA.

Can you have an impact on cancer? He did!

Page 60: Cancer: Are we closer to a cure? Thanks to: Jesse Boehm, Ph.D. Broad Institute of Harvard and MIT Cambridge, MA.

Points to rememberCancer is a family of similar diseases, not just one!

Different cancers have different causes, treatments and outcomes

Cancer is caused by MUTATIONS• Prevent your exposure to mutagens!

A tumor causes a patient harm by becoming malignant and metastasizing

By learning more about cancer we are developing new,

“smarter” cancer drugs More effective Fewer side effects


Recommended